Showing results (3971-3980 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|April 20, 2010
Anaphylactoid reaction considered ciprofloxacin related: a case report and literature reviewTheodoros Kelesidis, Jorge Fleisher, Sotirios TsiodrasClinical Therapeutics|April 20, 2010
Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjectsSusana Almeida, Augusto Filipe, Rita Neves, et al.Clinical Therapeutics|April 20, 2010
Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteersHuizhe Wu, Mingyan Liu, Shuang Wang, et al.Clinical Therapeutics|April 20, 2010
Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteersMahmood Ahmad, Fahad PervaizClinical Therapeutics|March 14, 2009
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registriesZuzana Motovska, Petr KalaClinical Therapeutics|December 26, 2008
Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover studyGuillermo Di Girolamo, Guillermo A Keller, Antonio R de Los Santos, et al.Clinical Therapeutics|December 26, 2008
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reductionDavid S Wald, Malcolm Law, Sarah Mills, et al.Clinical Therapeutics|December 26, 2008
Assessing prescriptions for statins in ambulatory diabetic patients in the United States: a national, cross-sectional studyLarry W Segars, Amanda R LeaClinical Therapeutics|October 9, 2008
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I studyAnna Solans, Iñaki Izquierdo, Esther Donado, et al.Pageof 680